Erik A. Bey
Assistant Professor
Clinical Pharmacy
West Virginia University
United States of America
Biography
Dr. Bey is an Assistant Professor in the School of Pharmacy and a member of the Sara Crile Allen and James Frederick Allen Lung Cancer Program in the WVU Cancer Institute. His interests include developing novel therapeutics for treatment of lung cancer with a focus on genes that regulate oxidative stress.
Research Interest
Oxidative stress and carcinogenesis,EMT and MET,Metastasis,Radiobiology,Nano-medicine,Quinone therapeutic
Publications
-
Morales J, Li L, Fattah FJ, Dong Y, Bey EA, Patel M, Gao J, Boothman DA. Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases. Critical Reviewsâ„¢ in Eukaryotic Gene Expression. 2014;24(1).
-
Madajewski B, Boatman MA, Chakrabarti G, Boothman DA, Bey EA. Depleting tumor-NQO1 potentiates anoikis and inhibits growth of NSCLC. Molecular Cancer Research. 2016 Jan 1;14(1):14-25.
-
Huang X, Motea EA, Moore ZR, Yao J, Dong Y, Chakrabarti G, Kilgore JA, Silvers MA, Patidar PL, Cholka A, Fattah F. Leveraging an NQO1 bioactivatable drug for tumor-selective use of poly (ADP-ribose) polymerase inhibitors. Cancer cell. 2016 Dec 12;30(6):940-52.
